| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.02 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |